Improving early lung cancer detection in diverse populations

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial aims to identify high-risk individuals for lung cancer who currently do not qualify for low-dose computed tomography (LDCT) screening. It will also establish a framework for managing patients with incidental pulmonary nodules (IPNs) through accurate interpretation of existing chest CT scans. Additionally, the study seeks to develop a minimally invasive test using breath samples and blood proteins to differentiate between cancerous and non-cancerous nodules. Participants will provide demographic and health-related information to aid in the assessment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Age 50-80

* Able to consent
* Chest CT positive for nodule equal to or greater than 6mm
* No additional other cancer- (outside of lung cancer for group 1)
* Must be able to abstain from smoking tobacco for 24 hours prior to the breath test.

Exclusion Criteria:

* Too sick to provide a breath sample
* you have smoked in the last 24 hours
* You are pregnant
* You have been diagnosed with a respiratory infection in the last 3 months
* Unwilling to consent to the study

Where it's running

• BC Cancer Research, part of the Provincial Health Authority
  Vancouver, British Columbia, Canada Recruiting

Study contacts

• Principal investigator: Renelle L Myers, MD — Vch, Ubc
• Study coordinator: Renelle L Myers, MD
• Email: renelle.myers@vch.ca
• Phone: 6046758096

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• European registry tracking use of the Ion system for lung nodule biopsy and localization

  This will collect real-world data to see how well the Ion endoluminal system works for adults having elective lung nodule biopsies or localization procedures.

  Recruiting at 7 sites Intuitive Surgical · Brest and 8 other locations · NCT06923774

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

• Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment

  This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07816263

• ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients

  This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.

  Recruiting at 2 sites Tam Anh Research Institute · Hanoi, Hanoi and 1 other locations · NCT07808164

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.